{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-028628","form_type":"8-K","ticker":"INBP","cik":"0001016504","company_name":"INTEGRATED BIOPHARMA INC","filed_at":"2026-08-20T19:27:04+00:00","discovered_at":"2026-08-20T19:28:02.627923+00:00","generated_at":"2026-08-20T19:28:11.644403+00:00","sec_items":["8.01","9.01","2.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Integrated BioPharma's MDC subsidiary names Michael Richtmyer Head of Operations","bullets":["Michael G. Richtmyer appointed Head of Operations at Manhattan Drug Company, effective August 3, 2026.","Richtmyer brings 35+ years in pharma/nutraceutical ops; was President of Tishcon Corp., overseeing 2 contract manufacturing sites.","He previously worked at Integrated BioPharma from 1991 to 1999 and returns with expanded leadership experience.","Will lead manufacturing, supply chain, quality systems, and scalable growth across MDC."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-028628","json":"https://secwatch.observer/filing/0001437749-26-028628.json","markdown":"https://secwatch.observer/filing/0001437749-26-028628.md","text":"https://secwatch.observer/filing/0001437749-26-028628.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1016504/000143774926028628/0001437749-26-028628-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1016504/000143774926028628/inbp20260820_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-20T19:28:11.644403+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}